CTChizu Tanikawa

Chizu Tanikawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chizu Tanikawa has a total of 648 co-authors. Here are the top co-authors by number of shared publications:

  • Koichi Matsuda

    Laboratory of Clinical Genome Sequencing, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan

    55 shared publications
  • Yusuke Nakamura

    Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

    27 shared publications
  • Michiaki Kubo

    RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan

    18 shared publications
  • Atsushi Takahashi

    RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan

    12 shared publications
  • Keitaro Matsuo

    Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan

    11 shared publications
  • Paulisally Hau Yi Lo

    Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

    8 shared publications

Latest Publications

  • Open Access

    Genome-wide association meta-analysis of atrophic gastritis reveals anti– H. pylori IgG serostatus-dependent associations and genetic overlap with gastric cancer

    by Tomoki Kyosaka, Akira Narita, Akimitsu Miyake, Yurii Kotsar, Takafumi Ojima, Shinichi Namba, Atsushi Shimizu, Yoichi Sutoh, Masahiro Nakatochi, Yuriko N. Koyanagi, et al.

    Background: Atrophic gastritis (AG), characterized by chronic inflammation of the gastric mucosa and glandular atrophy, is an established precursor of gastric cancer (GC) and contributes to iron-deficiency anemia, vitamin B12 deficiency, and pernicious anemia. Although Helicobacter pylori infection is a major environmental determinant, not all infected individuals develop AG or GC, suggesting that host genetic factors influence susceptibility to AG and severe atrophic gastritis (SAG). Previous genome-wide association studies (GWAS) of AG have been limited in size and have not adequately compared anti- H. pylori IgG serostatus strata, leaving potential genetic heterogeneity unresolved. Methods: We performed GWAS meta-analyses of AG and SAG, stratified by anti- H. pylori IgG serostatus, involving 214,747 Japanese participants: 75,074 in the discovery phase and 139,673 in the replication phase. Subsequent analyses included genotype-by-serostatus interactions, HLA allele and ABO blood group associations, genome-wide genetic correlations, multi-trait analysis, local genetic correlations, and structural equation modeling. In addition, cross-ancestry meta-analyses were performed using chronic gastritis GWAS data from FinnGen, UK Biobank, and the Million Veteran Program, comprising 1,357,053 participants. Results: Across six Japanese GWAS meta-analyses, we identified genome-wide significant associations at 17 genomic regions. Strong associations with seropositive AG/SAG were observed at previously reported GC susceptibility loci, including PSCA and MUC1 / MTX1 , whereas the MHC class II region showed predominant associations with seronegative AG/SAG. FAP , CCR6 , and ATP4A were also found to be associated with seronegative SAG. The identified regions included previously reported GC susceptibility regions MUC1 / MTX1 , PRKAA1 / PTGER4 , PSCA , ABO , and MHC. Associations at PSCA and MUC1 / MTX1 were replicated at a genome-wide significance level, supporting a shared genetic basis between AG/SAG and GC. Additional AG-associated candidate regions included BMP2 , CCDC80 , LRRC34 , CPEB4 , PGC / FRS3 , and LMTK2 , implicating epithelial regulation, immune responses, transcriptional regulation, and differentiation. A positive genotype-by-serostatus interaction for SAG was observed at MUC1 / MTX1 . HLA class II alleles, including HLA-DRB1*15:01 and HLA-DQB1*06:02 , showed associations with seronegative AG/SAG. The LDSC genetic correlation between AG and GC was 0.529, and the MTAG estimated Omega correlation was 0.694. Local genetic correlation analysis and structural equation modeling further supported shared genetic components. Cross-ancestry integration of seronegative SAG with external chronic gastritis GWAS data identified an additional association at TPTEP1 . Conclusions: Our findings characterize the genetic heterogeneity of serologically defined AG/SAG according to anti- H. pylori IgG serostatus. They highlight epithelial and mucus barrier-related pathways in seropositive AG/SAG and immune-related pathways in seronegative cases, while also providing evidence of a shared genetic basis between AG and GC. Together, these results clarify the genetic basis of a GC precursor and are consistent with a continuum from chronic inflammation through atrophy to carcinogenesis. These insights may inform prevention strategies and personalized management of the diverse health consequences of AG.

  • A large-scale microRNA transcriptome-wide association study identifies two susceptibility microRNAs, miR-1307-5p and miR-192-3p, for colorectal cancer risk

    by Zhishan Chen, Weiqiang Lin, Qiuyin Cai, Sun-Seog Kweon, Xiao-Ou Shu, Chizu Tanikawa, Wei-Hua Jia, Ying Wang, Xinwan Su, Yuan Yuan, et al.

    Transcriptome-wide association studies (TWAS) have identified many putative susceptibility genes for colorectal cancer (CRC) risk. However, susceptibility miRNAs, critical dysregulators of gene expression, remain unexplored. We genotyped DNA samples from 313 CRC East Asian patients and performed small RNA sequencing in their normal colon tissues distant from tumors to build genetic models for predicting miRNA expression. We applied these models and data from genome-wide association studies (GWAS) including 23 942 cases and 217 267 controls of East Asian ancestry to investigate associations of predicted miRNA expression with CRC risk. Perturbation experiments separately by promoting and inhibiting miRNAs expressions and further in vitro assays in both SW480 and HCT116 cells were conducted. At a Bonferroni-corrected threshold of P < 4.5 × 10−4, we identified two putative susceptibility miRNAs, miR-1307-5p and miR-192-3p, located in regions more than 500 kb away from any GWAS-identified risk variants in CRC. We observed that a high predicted expression of miR-1307-5p was associated with increased CRC risk, while a low predicted expression of miR-192-3p was associated with increased CRC risk. Our experimental results further provide strong evidence of their susceptible roles by showing that miR-1307-5p and miR-192-3p play a regulatory role, respectively, in promoting and inhibiting CRC cell proliferation, migration, and invasion, which was consistently observed in both SW480 and HCT116 cells. Our study provides additional insights into the biological mechanisms underlying CRC development.


  • Top Cited Papers

    Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases

    by Kazuyoshi Ishigaki, Masato Akiyama, Masahiro Kanai, Atsushi Takahashi, Eiryo Kawakami, Hiroki Sugishita, Saori Sakaue, Nana Matoba, Siew-Kee Low, Yukinori Okada, et al.

    The overwhelming majority of participants in current genetic studies are of European ancestry. To elucidate disease biology in the East Asian population, we conducted a genome-wide association study (GWAS) with 212,453 Japanese individuals across 42 diseases. We detected 320 independent signals in 276 loci for 27 diseases, with 25 novel loci (P < 9.58 × 10−9). East Asian–specific missense variants were identified as candidate causal variants for three novel loci, and we successfully replicated two of them by analyzing independent Japanese cohorts; p.R220W of ATG16L2 (associated with coronary artery disease) and p.V326A of POT1 (associated with lung cancer). We further investigated enrichment of heritability within 2,868 annotations of genome-wide transcription factor occupancy, and identified 378 significant enrichments across nine diseases (false discovery rate < 0.05) (for example, NKX3-1 for prostate cancer). This large-scale GWAS in a Japanese population provides insights into the etiology of complex diseases and highlights the importance of performing GWAS in non-European populations.


  • Open Access

    Claudin-2 deficiency associates with hypercalciuria in mice and human kidney stone disease

    by Joshua N. Curry, Matthew Saurette, Masomeh Askari, Lei Pei, Michael B. Filla, Megan R. Beggs, Peter S.N. Rowe, Timothy Fields, Andre J. Sommer, Chizu Tanikawa, et al.

    The major risk factor for kidney stone disease is idiopathic hypercalciuria. Recent evidence implicates a role for defective calcium reabsorption in the renal proximal tubule. We hypothesized that claudin-2, a paracellular cation channel protein, mediates proximal tubule calcium reabsorption. We found that claudin-2–null mice have hypercalciuria due to a primary defect in renal tubule calcium transport and papillary nephrocalcinosis that resembles the intratubular plugs in kidney stone formers. Our findings suggest that a proximal tubule defect in calcium reabsorption predisposes to papillary calcification, providing support for the vas washdown hypothesis. Claudin-2–null mice were also found to have increased net intestinal calcium absorption, but reduced paracellular calcium permeability in the colon, suggesting that this was due to reduced intestinal calcium secretion. Common genetic variants in the claudin-2 gene were associated with decreased tissue expression of claudin-2 and increased risk of kidney stones in 2 large population-based studies. Finally, we describe a family in which males with a rare missense variant in claudin-2 have marked hypercalciuria and kidney stone disease. Our findings indicate that claudin-2 is a key regulator of calcium excretion and a potential target for therapies to prevent kidney stones.


  • Identification of Novel Loci and New Risk Variant in Known Loci for Colorectal Cancer Risk in East Asians

    by Yingchang Lu, Sun-Seog Kweon, Qiuyin Cai, Chizu Tanikawa, Xiao-Ou Shu, Wei-Hua Jia, Yong-Bing Xiang, Jeroen R. Huyghe, Tabitha A. Harrison, Jeongseon Kim, et al.

    Background: Risk variants identified so far for colorectal cancer explain only a small proportion of familial risk of this cancer, particularly in Asians. Methods: We performed a genome-wide association study (GWAS) of colorectal cancer in East Asians, including 23,572 colorectal cancer cases and 48,700 controls. To identify novel risk loci, we selected 60 promising risk variants for replication using data from 58,131 colorectal cancer cases and 67,347 controls of European descent. To identify additional risk variants in known colorectal cancer loci, we performed conditional analyses in East Asians. Results: An indel variant, rs67052019 at 1p13.3, was found to be associated with colorectal cancer risk at P = 3.9 × 10–8 in Asians (OR per allele deletion = 1.13, 95% confidence interval = 1.08–1.18). This association was replicated in European descendants using a variant (rs2938616) in complete linkage disequilibrium with rs67052019 (P = 7.7 × 10–3). Of the remaining 59 variants, 12 showed an association at P < 0.05 in the European-ancestry study, including rs11108175 and rs9634162 at P < 5 × 10−8 and two variants with an association near the genome-wide significance level (rs60911071, P = 5.8 × 10−8; rs62558833, P = 7.5 × 10−8) in the combined analyses of Asian- and European-ancestry data. In addition, using data from East Asians, we identified 13 new risk variants at 11 loci reported from previous GWAS. Conclusions: In this large GWAS, we identified three novel risk loci and two highly suggestive loci for colorectal cancer risk and provided evidence for potential roles of multiple genes and pathways in the etiology of colorectal cancer. In addition, we showed that additional risk variants exist in many colorectal cancer risk loci identified previously. Impact: Our study provides novel data to improve the understanding of the genetic basis for colorectal cancer risk.


  • Open Access

    Identification of a novel uterine leiomyoma GWAS locus in a Japanese population

    by Kensuke Sakai, Chizu Tanikawa, Akira Hirasawa, Tatsuyuki Chiyoda, Wataru Yamagami, Fumio Kataoka, Nobuyuki Susumu, Chikashi Terao, Yoichiro Kamatani, Atsushi Takahashi, et al.

    Uterine leiomyoma is one of the most common gynaecologic benign tumours, but its genetic basis remains largely unknown. Six previous GWAS identified 33 genetic factors in total. Here, we performed a two-staged GWAS using 13,746 cases and 70,316 controls from the Japanese population, followed by a replication analysis using 3,483 cases and 4,795 controls. The analysis identified 9 significant loci, including a novel locus on 12q23.2 (rs17033114, P = 6.12 × 10−25 with an OR of 1.177 (1.141-1.213), LINC00485). Subgroup analysis indicated that 5 loci (3q26.2, 5p15.33, 10q24.33, 11p15.5, 13q14.11) exhibited a statistically significant effect among multiple leiomyomas, and 2 loci (3q26.2, 10q24.33) exhibited a significant effect among submucous leiomyomas. Pleiotropic analysis indicated that all 9 loci were associated with at least one proliferative disease, suggesting the role of these loci in the common neoplastic pathway. Furthermore, the risk T allele of rs2251795 (3q26.2) was associated with longer telomere length in both normal and tumour tissues. Our findings elucidated the significance of genetic factors in the pathogenesis of leiomyoma.


  • Open Access

    Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population

    by Siew-Kee Low, Yoon Ming Chin, Hidemi Ito, Keitaro Matsuo, Chizu Tanikawa, Koichi Matsuda, Hiroko Saito, Mika Sakurai-Yageta, Naoki Nakaya, Atsushi Shimizu, et al.

    Genome-wide association studies (GWAS) have successfully identified about 70 genomic loci associated with breast cancer. Owing to the complexity of linkage disequilibrium and environmental exposures in different populations, it is essential to perform regional GWAS for better risk prediction. This study aimed to investigate the genetic architecture and to assess common genetic risk model of breast cancer with 6,669 breast cancer patients and 21,930 female controls in the Japanese population. This GWAS identified 11 genomic loci that surpass genome-wide significance threshold of P < 5.0 × 10−8 with nine previously reported loci and two novel loci that include rs9862599 on 3q13.11 (ALCAM) and rs75286142 on 21q22.12 (CLIC6-RUNX1). Validation study was carried out with 981 breast cancer cases and 1,394 controls from the Aichi Cancer Center. Pathway analyses of GWAS signals identified association of dopamine receptor medicated signaling and protein amino acid deacetylation with breast cancer. Weighted genetic risk score showed that individuals who were categorized in the highest risk group are approximately 3.7 times more likely to develop breast cancer compared to individuals in the lowest risk group. This well-powered GWAS is a representative study to identify SNPs that are associated with breast cancer in the Japanese population.


  • Open Access

    Genetic variants of calcium and vitamin D metabolism in kidney stone disease

    by Sarah A. Howles, Akira Wiberg, Michelle Goldsworthy, Asha L. Bayliss, Anna K. Gluck, Michael Ng, Emily Grout, Chizu Tanikawa, Yoichiro Kamatani, Chikashi Terao, et al.

    Kidney stone disease (nephrolithiasis) is a major clinical and economic health burden with a heritability of ~45–60%. We present genome-wide association studies in British and Japanese populations and a trans-ethnic meta-analysis that include 12,123 cases and 417,378 controls, and identify 20 nephrolithiasis-associated loci, seven of which are previously unreported. A CYP24A1 locus is predicted to affect vitamin D metabolism and five loci, DGKD, DGKH, WDR72, GPIC1, and BCR, are predicted to influence calcium-sensing receptor (CaSR) signaling. In a validation cohort of only nephrolithiasis patients, the CYP24A1-associated locus correlates with serum calcium concentration and a number of nephrolithiasis episodes while the DGKD-associated locus correlates with urinary calcium excretion. In vitro, DGKD knockdown impairs CaSR-signal transduction, an effect rectified with the calcimimetic cinacalcet. Our findings indicate that studies of genotype-guided precision-medicine approaches, including withholding vitamin D supplementation and targeting vitamin D activation or CaSR-signaling pathways in patients with recurrent kidney stones, are warranted.


  • Open Access

    Large scale genome-wide association study in a Japanese population identified 45 novel susceptibility loci for 22 diseases

    by Kazuyoshi Ishigaki, Masato Akiyama, Masahiro Kanai, Atsushi Takahashi, Eiryo Kawakami, Hiroki Sugishita, Saori Sakaue, Nana Matoba, Siew-Kee Low, Yukinori Okada, et al.

    INTRODUCTORY PARAGRAPH: The overwhelming majority of participants in current genetic studies are of European ancestry 1–3 , limiting our genetic understanding of complex disease in non-European populations. To address this, we aimed to elucidate polygenic disease biology in the East Asian population by conducting a genome-wide association study (GWAS) with 212,453 Japanese individuals across 42 diseases. We detected 383 independent signals in 331 loci for 30 diseases, among which 45 loci were novel ( P < 5 × 10 −8 ). Compared with known variants, novel variants have lower frequency in European populations but comparable frequency in East Asian populations, suggesting the advantage of this study in discovering these novel variants. Three novel signals were in linkage disequilibrium (r 2 > 0.6) with missense variants which are monomorphic in European populations (1000 Genomes Project) including rs11235604(p.R220W of ATG16L2 , a autophagy-related gene) associated with coronary artery disease. We further investigated enrichment of heritability within 2,868 annotations of genome-wide transcription factor occupancy, andidentified 378 significant enrichments across nine diseases (FDR < 0.05) (e.g. NF-κB for immune-related diseases). This large-scale GWAS in a Japanese population provides insights into the etiology of common complex diseases and highlights the importance of performing GWAS in non-European populations.


  • A Polymorphic Variant in p19Arf Confers Resistance to Chemically Induced Skin Tumors by Activating the p53 Pathway

    by Megumi Saito, Kazuhiro Okumura, Eriko Isogai, Kimi Araki, Chizu Tanikawa, Koichi Matsuda, Takehiko Kamijo, Ryo Kominami, Yuichi Wakabayashi